PROGRAMME / CONCLUSIONS

13 November 2008

8.30-9.30	Registration
9.30-10.50	SESSION I: REGAIN MOMENTUM
	Chair: Antonios Trakatellis, MEP, Member of the Standing Committee ENVI (Environment, Public Health and Food Safety), European Parliament
09.30-09.45	Research to combat HIV/AIDS, Malaria and Tuberculosis: Europe does not give up! Janez Potočnik Commissioner for Science and Research, European Commission
09.45-10.00	EU Member States stand together against three major Infectious diseases \| (7.5MB) Jean-François Delfraissy Director of Agence Nationale de Recherche sur le Sida et les Hépatites Virales, France
10.00-10.15	Towards a global research agenda on Poverty Related Diseases? \| (15MB) Tim Evans Assistant Director General, World Health Organisation, Geneva, Switzerland
10.15-10.35	The African partners: Needs and challenges of Poverty Related Diseases research in Africa \| (63.8MB) Wilfred Mbacham Cameroon coalition against malaria, University of Yaoundé I, Cameroon
10.35-10.50	The EU Framework Programme as a tool for research support \| (1.4MB) Manuel Hallen Acting Director Health Directorate, DG Research, European Commission
10.50-11.25	Coffee break
10.50	Press Conference (VIP Room)
11.25-12.45	SESSION II: KEEP FOCUS
	Chair: Arnd Hoeveler, Head of Unit Health biotechnology, DG Research, European Commission.
11.25-11.45	HIV/AIDS: Back to square one? \| (2.6MB) Robin Shattock St. George's Hospital Medical School, London, United Kingdom
11.45-12.05	Malaria: From research to disease control \| (11MB) Henri Vial Director Centre National de la Recherche Scientifique, Montpellier, France
12.05-12.25	Tuberculosis: Great achievements and new horizons \| (13.4MB) Stefan Kaufmann Director Dept. of Immunology, Max Planck Institute, Berlin, Germany
12.25-12.45	EDCTP: A unique European initiative for Africa \| (6.9MB) Charles Mgone Executive Director European and Developing Countries Clinical Trials Partnership, The Hague, Netherlands
12.45-14.15	Lunch
	Lessons learnt and future strategies Parallel breakout sessions on the 3 diseases
14.15-18.00	SESSION III: HIV/AIDS-OUTSMARTING THE VIRUS
	Chair: Marie Paule Kieny, Director Initiative for Vaccine Research, WHO, Geneva, Switzerland
	Areas to be addressed: Prevention: Speakers: Gerald Voss and Robin Shattock Rapporteur: Robin Shattock Treatment: Speakers: Jose Maria Gatell and Jan Balzarini Rapporteur: Jan Balzarini HIV and Public Health: Speakers: Jens Lundgren and Kholoud Porter Rapporteur: Jens Lundgren Cross cutting issues: Rapporteur: Klaus Ueberla Panel members: Jan Balzarini, Rega Institute for Medical Research, Leuven, Belgium Alan Bernstein, Global HIV Vaccine Enterprise, USA Nicos Dedes, European AIDS Treatment Group, Brussels José Esparza, Bill and Melinda Gates Foundation, USA Jean-François Delfraissy, Agence Nationale de Recherche sur le Sida, France Jose Maria Gatell, Hospital Clínic, University of Barcelona, Spain Andrzej Horban, Centre for Diagnosis and Therapy of AIDS, Warszaw, Poland Marie Paule Kieny, Initiative for Vaccine Research, WHO Geneva, Switzerland Jens Lundgren, Rigshospitalet and University of Copenhagen, Denmark Charles Mgone, EDCTP, The Hague,The Netherlands Kholoud Porter, Medical Research Council, London, United Kingdom Robin Shattock, St. George's Hospital Medical School, London, United Kingdom Klaus Ueberla, Ruhr-University Bochum, Germany Frans Van den Boom, Inter. AIDS Vaccine Initiative, Amsterdam, The Netherlands Fulvia Veronese, National Institutes of Health, Bethesda, USA Gerald Voss, Glaxo Smith Kline, Brussels, Belgium
14.15-18.00	SESSION IV: MALARIA-A MOVING TARGET
	Chair: Marita Troye-Blomberg, Director, Dept. of Immunology, University of Stockholm, Sweden
	Areas to be addressed: Immunopathogenesis and Vaccines: Speakers: Louis Miller and Odile Leroy/Ashley Birkett (EMVI/MVI) Rapporteur: Roma Chilengi and Andrian Luty Parasites and Drugs: Speakers: Hagai Ginsburg and I. Bathurst (MMV) Rapporteur: Mike Blackman and Henri Vial Vectors and Transmission of Disease: Speakers: Bob Sinden Rapporteur: Andy Waters and Didier Fontenille Malaria Control including Diagnostics: Speakers: Peter Kremsner and Pedro Alonso Rapporteur: Zeno Bisoffi and Wilfred Mbacham Cross cutting issues: Rapporteur: Zeno Bisoffi Panel members: Pedro Alonso, Centre for International Health Research Hospital Clinic- University of Barcelona, Spain Ian Bathurst, Medicines for Malaria Venture, Geneva, Switzerland Mike Blackman, National Institute for Medical Research, London, United Kingdom Ashley Birkett, PATH Malaria Vaccine Initiative, Seattle, USA Zeno Bisoffi, Centre for Tropical Diseases S. Cuore Hospital, Negrar, Verona, Italy Roma Chilengi, Kemri-Wellcome Trust Research Programme, Kilifi, Kenya Didier Fontenille, Institut de recherche pour le développement, Montpellier, France Hagai Ginsburg, Institute of Life SciencesHebrew University, Jerusalem, Israel Peter Kremsner, University of Tuebingen, Germany Odile Leroy, European Malaria Vaccine Initiative, Denmark Adrian Luty, Radboud University Nijmegen Medical Centre, Nigmegen, The Netherlands Janos Marki-Zay, Solvo Biotechnology, Budapest, Hungary Wilfred Mbacham, The Biotechnology Centre, University of Yaounde I, Cameroon Louis Miller, National Institutes of Health, USA Robert Sinden, Imperial College, London, United Kingdom Marita Troye-Blomberg, Dept. of Immunology, University of Stockholm, Sweden Henri Vial, CNRS, Université Montpellier II, France Andy Waters, University of Glasgow, United Kingdom
14.15-18.00	SESSION V: TUBERCULOSIS-LOOKING BEYOND
	Chair: Ali Zumla, Director Centre for Infectious Diseases, University College of London, United Kingdom
	Areas to be addressed: Vaccines: Speakers:Paul-Henri Lambert Rapporteur: Jelle Thole Drugs: Speakers: Stewart Cole and Zhenkun Ma Rapporteur: Christian Lienhardt Diagnostics: Speakers: Douglas Young and Mark Perkins Rapporteur: Gerd Michel Global Coordination: Mario Raviglione and Peter Small Rapporteur: Louise Baker Cross cutting issues: Rapporteur: Vince Grolmusz Panel members: Stewart Cole, Ecole Polytechnique Fédérale, Lausanne, Switzerland Brigitte Gicquel, Institut Pasteur, Paris, France Vince Grolmusz, Eotvos University & Uratim Ltd, Budapest, Hungary Gregory Hussey, South African TB Vaccine Initiative, Cape Town, South Africa Stefan Kaufmann - Max Planck Institute for infection Biology, Berlin, Germany Christian Lienhardt, Institut de recherche pour le développement, Paris, France Paul-Henri Lambert, Centre for Vaccinology, Geneva, Switzerland Zhenkun Ma, TB Alliance,NY, USA Gerd Michel, Foundation for Innovative New Diagnostics, Geneva, Switzerland Philip Onyebujoh, WHO/TDR, Geneva, Switzerland Tony Hawkridge, Aeras, Cape Town, South Africa Mark Perkins, Foundation for Innovative New Diagnostics, Geneva, Switzerland Mario Raviglione, STOP TB Department, WHO, Geneva, Switzerland Melvin Spigelman, TB Alliance, NY, USA Peter Small, Global Health Program, Bill and Melinda Gates Foundation, Seattle, USA Jelle Thole, TB Vaccine Initiative, Lelystad, The Netherlands Alimuddin Zumla, University College London Medical School, London, UK
18.00-20.00	Reception

	14 November 2008
9.00-13.15	SESSION VI: REPORTS FROM THE BREAKOUT SESSIONS
	Chair: Michel Pletschette, DG SANCO, European Commission Irene Horejs, Human Development, Social Cohesion and Employment, DG DEV, European Commission
09.00-10.00	HIV/AIDS Chair: Marie Paule Kieny, Director Initiative for Vaccine Research, WHO Geneva, Switzerland Open discussion
10.00-11.00	Malaria \| (448kb) Chair: Marita Troye-Blomberg, Director, Dept. of Immunology, University of Stockholm, Sweden Open discussion
11.00-11.30	Coffee break
11.30-12.30	Tuberculosis \| (112kb) Chair: Ali Zumla, Director Centre for Infectious Diseases, University College of London, United Kingdom Open discussion
12.30-13.00	PRDs research: Where do we go from here? Bruno Gryseels, Director Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium \| (36.4MB)
13.00-13.15	Concluding remarks José Manuel Silva Rodríguez, Director General DG Research, European Commission

European Commission

PROGRAMME / CONCLUSIONS

13 November 2008

14 November 2008